Ildong Pharmaceutical Co., Ltd. (249420.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩12,600 (+1.61%) as of
Key statistics
- Market cap
- 397.00B
- Dividend yield
- 1.61%
- 52-week range
- 11,250.00 – 45,050.00
- Beta
- 0.89
- Revenue (TTM)
- 582.33B
- Profit margin
- 7.49%
- Volume
- 54.23k
About Ildong Pharmaceutical Co., Ltd.
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 1,050
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.